Lack of macrophage fatty-acid–binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis

被引:573
作者
Liza Makowski [1 ]
Jeffrey B. Boord [2 ]
Kazuhisa Maeda [1 ]
Vladimir R. Babaev [2 ]
K. Teoman Uysal [1 ]
Maureen A. Morgan [5 ]
Rex A. Parker [5 ]
Jill Suttles [6 ]
Sergio Fazio [2 ]
Gökhan S. Hotamisligil [3 ]
MacRae F. Linton [1 ]
机构
[1] Harvard School of Public Health,Division of Biological Sciences and Department of Nutrition
[2] Vanderbilt University Medical Center,Department of Medicine
[3] Vanderbilt University Medical Center,Department of Pathology
[4] Vanderbilt University Medical Center,Department of Pharmacology
[5] Bristol-Myers Squibb PRI,Department of Metabolic Research
[6] University of Louisville School of Medicine,Department of Microbiology and Immunology
关键词
D O I
10.1038/89076
中图分类号
学科分类号
摘要
The adipocyte fatty-acid–binding protein, aP2, has an important role in regulating systemic insulin resistance and lipid metabolism. Here we demonstrate that aP2 is also expressed in macrophages, has a significant role in their biological responses and contributes to the development of atherosclerosis. Apolipoprotein E (ApoE)-deficient mice also deficient for aP2 showed protection from atherosclerosis in the absence of significant differences in serum lipids or insulin sensitivity. aP2-deficient macrophages showed alterations in inflammatory cytokine production and a reduced ability to accumulate cholesterol esters when exposed to modified lipoproteins. Apoe−/− mice with Ap2+/+ adipocytes and Ap2−/− macrophages generated by bone-marrow transplantation showed a comparable reduction in atherosclerotic lesions to those with total aP2 deficiency, indicating an independent role for macrophage aP2 in atherogenesis. Through its distinct actions in adipocytes and macrophages, aP2 provides a link between features of the metabolic syndrome and could be a new therapeutic target for the prevention of atherosclerosis.
引用
收藏
页码:699 / 705
页数:6
相关论文
empty
未找到相关数据